A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

Overview of attention for article published in Multiple Sclerosis Journal, January 2011

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 Google+ post.

https://www.ncbi.nlm.nih.gov/pubmed/21228027 https://www.ncbi.nlm.nih.gov/pubmed/21228027 A Swedish national post-marketing…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.